CVE-2018-18564

Description

An issue was discovered in Roche Accu-Chek Inform II Instrument before 03.06.00 (Serial number below 14000) and 04.x before 04.03.00 (Serial Number above 14000), CoaguChek Pro II before 04.03.00, and cobas h 232 before 04.00.04 (Serial number above KQ0400000 or KS0400000). Improper access control allows attackers in the adjacent network to change the instrument configuration.

7.4

CVSS

Severity: High

CVSS 3.0 •

CVSS 2.0 •

EPSS 0.18%

Third-Party Advisory securityfocus.com Third-Party Advisory us-cert.gov

Affected: n/a n/a

References

Link	Tags
https://ics-cert.us-cert.gov/advisories/ICSMA-18-310-01	us government resource third party advisory mitigation
http://www.securityfocus.com/bid/105843	vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2018-18564?: CVE-2018-18564 has been scored as a high severity vulnerability.
How to fix CVE-2018-18564?: To fix CVE-2018-18564, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-18564 being actively exploited in the wild?: As for now, there are no information to confirm that CVE-2018-18564 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.